Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“In 2016, the DEA rejected a petition to reschedule marijuana, citing marijuana's widespread use as evidence of its potential for abuse.”
UnverifiableConfidence: LOW

Reasoning

The claim matches the excerpt from the Reason.com article, which reports the DEA's 2016 decision and its rationale. No contradictory evidence is presented.

On confidence: The provided source directly states that the DEA rejected a 2016 petition to reschedule marijuana and cited its widespread use as evidence of abuse potential.

Important context

The DEA's justification focused on the prevalence of marijuana use rather than quantitative comparisons of addictiveness to other substances.

Evidence

Supporting (1)

  • Tier 1 — Primary source
    The way the FDA and DEA ban drugs is unaccountable and arbitrary

    bend the concept of abuse potential without accountability. When the DEA rejected a petition to reschedule marijuana in 2016, it cited marijuana's widespread use as evidence of its potential for abuse, without providing quantitative…

Limitations

The assessment relies on a single secondary source; primary DEA documents were not consulted. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 1, 2026, 4:11 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

The Way the FDA and DEA Ban Drugs Is Unaccountable and Arbitrary

Reason · Ryan Curtis